According to filings with the U.S. Securities and Exchange Commission, Health Precision dba Medical Brain is raising up to $10,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Health Precision dba Medical Brain
healthPrecision is revolutionizing healthcare delivery with its cutting-edge Medical Brain. As a leader in high-precision healthcare technology, the Medical Brain offers a comprehensive, real-time view of a patients clinical status 24/7. This innovative system empowers patients, providers, family members, and care coordinators to proactively address clinical issues, ensuring timely and effective interventions. By leveraging advanced algorithms and continuous monitoring, the Medical Brains primary objective is to maintain and optimize the patients health. Additionally, it delivers significant cost savings for providers by reducing hospital readmissions and improving care efficiency, setting a new standard for excellence in healthcare management.

To learn more about Health Precision dba Medical Brain, visit http://www.medicalbrain.com/
Health Precision dba Medical Brain Linkedin Page: https://www.linkedin.com/company/healthprecision-medicalbrain/

Contact:
Eyal Ephrat, Chief Executive Officer
646-844-1960
https://www.linkedin.com/in/eyal-ephrat-md-36524422/

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.